<DOC>
	<DOCNO>NCT00870441</DOCNO>
	<brief_summary>The objective study compare safety ASP2151 valacyclovir placebo healthy male female adult volunteer .</brief_summary>
	<brief_title>Study Comparing Safety ASP2151 Valacyclovir Placebo Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Healthy subject weigh least 45 kg Body Mass Index ( BMI ) 1835 kg/m2 , inclusive If female , subject use medically acceptable contraceptive method along doublebarrier method prevent pregnancy agree continue use method throughout study ; lactate pregnant document negative serum pregnancy test The subject medically healthy , normal 12lead electrocardiogram ( ECG ) History clinically significant disease malignancy exclude nonmelanoma skin cancer History liver disease , liver dysfunction , liver enzyme elevation , Gilbert 's disease History acute chronic pancreatitis pancreatic insufficiency History gout , hyperuricemia , crystalluria History chronic pain require medical therapy Positive test hepatitis C virus ( HCV ) antibody hepatitis B surface antigen ( HBsAg ) Positive test human immunodeficiency virus ( HIV ) antibody Clinical laboratory test outside normal limit consider investigator clinically significant The subject difficulty swallow tablet Clinically significant illness within one month prior study drug administration History drug alcohol abuse within 2 year prior study drug administration Treatment prescription medication ( exception contraceptives hormone replacement therapy ( HRT ) ) complementary alternative medicine ( CAM ) within 14 day ; overthecounter product exception ibuprofen within 14 day ; alcohol , grapefruit grapefruit juice contain beverage within 72 hour Donated blood significant blood loss within 56 day prior study drug administration donate plasma within 7 day prior study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>ASP2151</keyword>
	<keyword>Valacyclovir</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>